Vivo Bio Tech Ltd — Updates, 17-04-2025: Company Update

Vivo Bio Tech Limited has allotted 4,48,889 equity shares at an issue price of Rs. 45 each, resulting from the conversion of warrants on a preferential basis. Promoters Kompella Ramakrishna Paramahamsa and Kompella Lopa Mudra received 2,88,889 and 1,60,000 shares, respectively. This move increases the company's subscribed share capital to Rs. 17.92 crore, enhancing its equity base.

This expansion could bolster investor confidence and potentially improve liquidity, presenting a positive outlook. However, the increased equity may dilute existing shareholdings, necessitating careful monitoring from investors.